Fut, nem toborozFázis nélkül
BGP+ Stent as Bridging Stent in BEVAR
A legfontosabb adatok
- Ki végzi
- Marc Bosiers, MD
- Hol
- Németország10 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 118 fő, tervezett
- Kezdés
- 2020. szept. 9.
- Befejezés
- 2025. júl. 31.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- BGP+ Stent Graft System as bridging stent
- A regiszteradat frissítve
- 2025. április 9.
Ki vehet részt
- Életkor
- 55 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 34 feltétel megnézéseKevesebb
Ki vehet részt
- Patient eligible for elective repair of TAAA with BEVAR in accordance with the applicable guidelines for vascular interventions (e.g. Aneurysm size 6cm or aneurysm growth of >5mm within 6 months or 1cm within 1 year)
- Patient is willing to comply with specified follow-up evaluations at the specified times
- Patient is >55 years old
- Patient understands the nature of the procedure and provides written informed consent, prior to enrolment in the trial; Patient has a projected life-expectancy of at least 12-months
- Patient needs to have a landing zone in their target vessel of at least 15 mm, and coverage/ wall adaptation of the BGP+ should be obtained for at least 10 mm
- The access vessel for introduction of the sheath through which the BGP+ will be advanced should be at least 3mm (it should be able to fit a 8F sheath)
- No early important division branch from the target vessel with risk of coverage
- Absence of pre-existing dissection in the target vessels
- Target vessels (renal arteries, superior mesenteric artery, and celiac trunk) for the BGP+ must have a diameter between 5 and 10 mm
- Aortic endoprosthesis with inner branches (can be hybrid or branches only)
- Hybrid aortic endoprosthesis with fenestrations and branches (at least 2 and only the target vessels which are connected by a branch shall be treated with a study device within this study)
- At least one target vessel is bridged with only one BGP+ (relining allowed)
- Full compliance with all inclusion criteria/exclusion criteria and all intraoperative criteria
Ki nem vehet részt
- Previously implanted stent in the target vessel
- Patients for whom antiplatelet therapy, anticoagulants or thrombolytic drugs are contraindicated
- Any planned surgical intervention/procedure within 30 days of the trial procedure
- Patient is currently participating in another conflicting investigational drug or device trial that has not completed the entire follow up period
- Hybrid Approach (endovascular in combination with open surgery)
- Myocardial infarction or stroke within 3 months prior to the procedure
- Patients with uncorrected bleeding disorders or heparin induced thrombocytopenia
- Patients with diffuse distal disease resulting in poor stent outflow
- Patients with known hypersensitivity to the stent material (L605) and/or PTFE
- Patients with a connective tissue disorder
- Patients with an unstable angina pectoris or heart insufficiency NYHA 3 or 4
- Patients with access vessel which are too tortuous, narrow or any kind of reason that would lead to failure of introducing and advancing an introducer sheath
- Renal artery with >100° cranial orientation
- Patients refusing treatment
- Female patient with childbearing potential not taking adequate contraceptives or currently breastfeeding
- Patients with rupture or any patient considered to be hemodynamically unstable at onset of procedure
- Fresh thrombus formation within the last 14 days
- Patients with mycotic or inflammatory aneurysm
- Patients with ASA classification 5 or higher
- Contraindications against contrast enhanced angiography (a.e. massive hyperthyroidism)
- Patients with increased risk of intraoperative rupture
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The objective of this clinical investigation is to evaluate, in a controlled setting, the safety and performance of the BGP+ balloon expandable covered stent Graft System (Bentley InnoMed, Hechingen, Germany) implanted as bridging stent in BEVAR (branched endovascular aortic repair) for complex aortic aneurysms.
A vizsgálat csoportja
- BGP+ Stent Graft SystemA vizsgált kezelés
Application of BeGraft Peripheral Plus (BGP+) Stent Graft System as bridging stent in Branched Endovascular Repair (BEVAR) for complex aortic aneurysms
Kezelés: BGP+ Stent Graft System as bridging stent
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Physician-Initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System as Bridging Stent in BEVAR for Complex Aortic Aneurysms
- A regiszteradat frissítve
- 2025. április 9.